| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 7,121 | 4,403 | | Cost of Revenue | 1,504 | 1,205 | | | Gross Profit | 5,617 | 3,198 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 129 | 94 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 5,487 | 3,104 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (86,807) | (44,408) | | Earnings Before Interest And Taxes | 5,487 | 3,104 | | Interest Expense |
-
|
-
| | Income Before Tax | 5,487 | 3,104 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (81,320) | (41,304) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (81,320) | (41,304) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($81,320) | ($41,304) |
|
0.83% Nasdaq 
Income Statement
